Parnax Lab (BOM:506128) Total Equity: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506128 Parnax Lab Ltd BOM:506128
68 GF Score
Price ₹119.15
GF Value ₹149.51
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Parnax Lab Total Equity?

Parnax Lab BOM:506128 +1.21% 68 Total Equity is ₹ Mil as of Jun. 2026. GuruFocus rates BOM:506128 with a GF Score™ of 68/100 and a GF Value™ of ₹149.51 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Parnax Lab's total equity for the quarter that ended in Jun. 2026 was ₹ Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Parnax Lab Total Equity Historical Data

* Premium members only.

The historical data trend for Parnax Lab's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Parnax Lab Total Equity Chart

Parnax Lab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 482.78 622.61 716.95 832.42 953.00

Parnax Lab Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 901.40 - 953.00 -
BOM:506128
68GF Score
Parnax Lab Ltd BOM:506128
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Parnax Lab Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Parnax Lab's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2276.297-1323.301
=953

Parnax Lab's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹ Mil mean?
Parnax Lab (BOM:506128) has a Total Equity of ₹ Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Parnax Lab and its competitors.
Is Parnax Lab's Total Equity too high?
Parnax Lab's current Total Equity is ₹ Mil. Overall, Parnax Lab has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Parnax Lab's Total Equity compare to ZTS?
Parnax Lab's Total Equity of ₹ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Parnax Lab and its competitors. Parnax Lab's current Total Equity is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Parnax Lab stock overvalued right now?
Based on GuruFocus' analysis, Parnax Lab (BOM:506128) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹149.51, compared to a current price of ₹119.15 — trading 20.3% below its estimated fair value. The current Total Equity is ₹ Mil. Parnax Lab's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Parnax Lab (BOM:506128), the current Total Equity is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Parnax Lab (BOM:506128) Overvalued in 2026?

Based on GuruFocus' analysis, Parnax Lab stock appears to be undervalued. The current stock price of ₹119.15 is trading 20.3% below its estimated GF Value™ of ₹149.51. GuruFocus considers Parnax Lab to be Modestly Undervalued.

Key valuation signals for BOM:506128:

  • Total Equity: ₹ Mil
  • GF Value™: ₹149.51 vs. price of ₹119.15 (20.3% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the BOM:506128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Parnax Lab Business Description

Other Exchanges PARNAXLAB:India
Address 104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.
68GF Score

Get the complete analysis for BOM:506128

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹119.15
Price
₹149.51
GF Value